Prodigiosin and its derivatives as new options for melanoma treatment (2017)
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Workshop on Melanoma Models. Unidades: FCFRP, FCF, ICB
Assunto: MELANOMA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BRANCO, Paola Cristina et al. Prodigiosin and its derivatives as new options for melanoma treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo. . Acesso em: 30 maio 2024. , 2017APA
Branco, P. C., Pontes, C. A., Bauermeister, A., Fernandes, D. K. A., Hirata, A. S., Jimenez, P. C., et al. (2017). Prodigiosin and its derivatives as new options for melanoma treatment. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas de Ribeirão Preto, Universidade de São Paulo.NLM
Branco PC, Pontes CA, Bauermeister A, Fernandes DKA, Hirata AS, Jimenez PC, Lopes NP, Maria-Engler SS, Lotufo LVC. Prodigiosin and its derivatives as new options for melanoma treatment. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 28 res. WM-031.[citado 2024 maio 30 ]Vancouver
Branco PC, Pontes CA, Bauermeister A, Fernandes DKA, Hirata AS, Jimenez PC, Lopes NP, Maria-Engler SS, Lotufo LVC. Prodigiosin and its derivatives as new options for melanoma treatment. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 28 res. WM-031.[citado 2024 maio 30 ]